The European Commission has approved The Protein Brewery's Fermotein mycoprotein, marking the first novel mycelium ingredient authorized for sale in the EU under the Novel Food Regulation, with market availability expected by Q3 2026. This approval, which follows a lengthy six-year review process, is seen as a significant milestone for food technology and the broader European food biotech sector.
The European Commission's approval of The Protein Brewery's Fermotein mycoprotein as a novel food marks a significant regulatory milestone, setting a precedent for other foodtech innovations in Europe. This decision highlights the potential for mycelium-based proteins to enter mainstream markets, but also underscores the need for faster regulatory processes to keep pace with food innovation. For industry stakeholders, this presents an opportunity to push for regulatory reforms that can streamline the approval process for novel foods, potentially accelerating market entry for alternative proteins.